Recover the lost art of drug discovery

Kim Lewis ()
Additional contact information
Kim Lewis: Kim Lewis is director of the antimicrobial discovery center, Northeastern University, Boston, Massachusetts 02115, USA. K.L. sits on the board of directors at NovoBiotic Pharmaceuticals in Cambridge, Massachusetts, and at Arietis Corporation in Boston.

Nature, 2012, vol. 485, issue 7399, 439-440

Abstract: Bacterial evolution is overwhelming our antibiotic defences, says Kim Lewis. Using modern technology to replicate past success might tip the balance in our favour.

Date: 2012
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/485439a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:485:y:2012:i:7399:d:10.1038_485439a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/485439a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().